ADPT insider filings
Adaptive Biotechnologies Corp — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-13. Screen ADPT transaction legs live →
Insider transaction summary — last 90 days
2026-08-23 to 2026-11-21, from the filings listed below: 19 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 65 legs across 17 filings by 4 insiders — 541,104 shares, $14,724,890 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 80.
- Largest priced transaction: sale of 107,537 shares @ $28.02 ($3,013,187) by LO FRANCIS, filed 2026-09-18.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| RUBINSTEIN JULIE — President and COO | 11 | — | 57 legs · 379,777 sh · $10,193,614 | 64 |
| LO FRANCIS — Chief People Officer | 2 | — | 4 legs · 142,198 sh · $3,995,701 | 14 |
| BOBULSKY SUSAN — Chief Commercial Officer, MRD | 3 | — | 3 legs · 9,514 sh · $285,585 | — |
| OWEN KATEY EINTERZ — Director | 2 | — | 1 leg · 9,615 sh · $249,990 | 1 |
| ROBINS CHAD M — CEO and Chairman, Director | 1 | — | — | 1 |
Recent insider filings — Adaptive Biotechnologies Corp
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-13 | 4 | RUBINSTEIN JULIE — President and COO | Option exercise (M): 11,881 @ $12.14 · Sale (S): 4,983 @ $30.29 · Sale (S): 6,898 @ $31.22 · Option exercise (M): 11,881 @ $12.14 · Sale (S): 11,881 @ $29.40 · Option exercise (M): 11,466 @ $12.14 · +4 more | EDGAR |
| 2026-11-13 | 4 | BOBULSKY SUSAN — Chief Commercial Officer, MRD | Sale (S): 1,875 @ $32 | EDGAR |
| 2026-11-12 | 4 | ROBINS CHAD M — CEO and Chairman, Director | Gift (G): 100,000 @ $0 | EDGAR |
| 2026-11-10 | 4 | RUBINSTEIN JULIE — President and COO | Option exercise (M): 11,881 @ $12.14 · Sale (S): 1,100 @ $28.87 · Sale (S): 8,381 @ $30.15 · Sale (S): 2,400 @ $30.58 · Option exercise (M): 11,881 @ $12.14 · Sale (S): 9,981 @ $29.35 · +3 more | EDGAR |
| 2026-11-06 | 4 | RUBINSTEIN JULIE — President and COO | Option exercise (M): 11,881 @ $12.14 · Sale (S): 4,000 @ $25.78 · Sale (S): 7,881 @ $26.60 · Option exercise (M): 11,881 @ $12.14 · Sale (S): 5,926 @ $26.10 · Sale (S): 5,455 @ $26.88 · +7 more | EDGAR |
| 2026-11-03 | 4 | RUBINSTEIN JULIE — President and COO | Option exercise (M): 11,881 @ $12.14 · Sale (S): 9,486 @ $26.55 · Sale (S): 2,395 @ $27.45 · Option exercise (M): 11,881 @ $12.14 · Sale (S): 9,296 @ $25.23 · Sale (S): 2,585 @ $26.34 · +5 more | EDGAR |
| 2026-10-29 | 4 | RUBINSTEIN JULIE — President and COO | Option exercise (M): 11,881 @ $12.14 · Sale (S): 3,000 @ $26.58 · Sale (S): 8,881 @ $27.53 · Option exercise (M): 11,881 @ $12.14 · Sale (S): 11,681 @ $28.44 · Sale (S): 200 @ $28.90 · +5 more | EDGAR |
| 2026-10-26 | 4 | RUBINSTEIN JULIE — President and COO | Option exercise (M): 11,881 @ $12.14 · Sale (S): 10,181 @ $24.38 · Sale (S): 1,700 @ $25.29 · Option exercise (M): 11,881 @ $12.14 · Sale (S): 4,500 @ $24.50 · Sale (S): 7,381 @ $25.28 · +6 more | EDGAR |
| 2026-10-21 | 4 | RUBINSTEIN JULIE — President and COO | Option exercise (M): 11,881 @ $12.14 · Sale (S): 11,881 @ $24.05 · Option exercise (M): 11,881 @ $12.14 · Sale (S): 11,781 @ $24.53 · Sale (S): 100 @ $24.85 · Option exercise (M): 11,881 @ $12.14 · +5 more | EDGAR |
| 2026-10-16 | 4 | RUBINSTEIN JULIE — President and COO | Option exercise (M): 11,881 @ $12.14 · Sale (S): 6,781 @ $25.57 · Sale (S): 5,100 @ $25.82 · Option exercise (M): 11,881 @ $12.14 · Sale (S): 11,881 @ $25.61 · Option exercise (M): 11,881 @ $12.14 · +5 more | EDGAR |
| 2026-10-13 | 4 | RUBINSTEIN JULIE — President and COO | Option exercise (M): 11,881 @ $12.14 · Sale (S): 11,881 @ $26.41 · Option exercise (M): 11,881 @ $12.14 · Sale (S): 9,181 @ $25.35 · Sale (S): 2,700 @ $26.07 · Option exercise (M): 11,881 @ $12.14 · +4 more | EDGAR |
| 2026-10-08 | 4 | RUBINSTEIN JULIE — President and COO | Option exercise (M): 11,881 @ $12.14 · Sale (S): 9,381 @ $27.36 · Sale (S): 1,100 @ $28.21 · Sale (S): 901 @ $29.71 · Sale (S): 499 @ $30.53 · Option exercise (M): 11,881 @ $12.14 · +6 more | EDGAR |
| 2026-10-08 | 4 | BOBULSKY SUSAN — Chief Commercial Officer, MRD | Sale (S): 6,444 @ $30 | EDGAR |
| 2026-10-05 | 4 | RUBINSTEIN JULIE — President and COO | Option exercise (M): 11,881 @ $12.14 · Sale (S): 6,081 @ $27.57 · Sale (S): 5,800 @ $28.56 · Option exercise (M): 11,881 @ $12.14 · Sale (S): 11,881 @ $28.13 · Option exercise (M): 11,881 @ $12.14 · +5 more | EDGAR |
| 2026-10-05 | 4 | LO FRANCIS — Chief People Officer | Option exercise (M): 8,038 @ $8.46 · Option exercise (M): 9,377 @ $3.99 · Option exercise (M): 9,377 @ $8.12 · Sale (S): 8,094 @ $27.52 · Sale (S): 18,698 @ $28.61 · Option exercise (M): 8,038 (derivative) @ $0 · +2 more | EDGAR |
| 2026-09-18 | 4 | LO FRANCIS — Chief People Officer | Option exercise (M): 53,091 @ $12.14 · Option exercise (M): 13,398 @ $8.46 · Option exercise (M): 15,629 @ $3.99 · Option exercise (M): 23,442 @ $8.12 · Sale (S): 107,537 @ $28.02 · Sale (S): 7,869 @ $28.57 · +4 more | EDGAR |
| 2026-09-17 | 4 | BOBULSKY SUSAN — Chief Commercial Officer, MRD | Sale (S): 1,195 @ $27 | EDGAR |
| 2026-09-02 | 4 | OWEN KATEY EINTERZ — Director | Gift (G): 12,539 | EDGAR |
| 2026-08-28 | 4 | OWEN KATEY EINTERZ — Director | Sale (S): 9,615 @ $26 | EDGAR |
| 2026-08-20 | 4 | HERSHBERG ROBERT — Director | Option exercise (M): 15,000 @ $6.32 · Sale (S): 15,000 @ $24.39 · Sale (S): 15,664 @ $24.41 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2026-08-19 | 4 | ROBINS CHAD M — CEO and Chairman, Director | Option exercise (M): 321,324 @ $6.55 · Sale (S): 318,799 @ $25.08 · Sale (S): 2,525 @ $25.57 · Option exercise (M): 278,676 @ $6.55 · Sale (S): 278,472 @ $24.48 · Sale (S): 204 @ $25.14 · +2 more | EDGAR |
| 2026-08-19 | 4 | NEUPERT PETER M — Director | Option exercise (M): 15,000 @ $6.32 · Sale (S): 15,000 @ $25.23 · Sale (S): 40,000 @ $25.10 · Sale (S): 69,690 @ $25.16 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2026-08-12 | 4 | BOBULSKY SUSAN — Chief Commercial Officer, MRD | Sale (S): 3,000 @ $25 | EDGAR |
| 2026-08-03 | 4 | BOBULSKY SUSAN — Chief Commercial Officer, MRD | Sale (S): 1,299 @ $24 | EDGAR |
| 2026-07-23 | 4 | ROBINS HARLAN S — Chief Scientific Officer | Option exercise (M): 284,800 @ $6.55 · Sale (S): 278,698 @ $21.72 · Sale (S): 213,702 @ $22.12 · Option exercise (M): 284,800 (derivative) @ $0 | EDGAR |
| 2026-07-20 | 4 | BOBULSKY SUSAN — Chief Commercial Officer, MRD | Sale (S): 5,000 @ $23 | EDGAR |
| 2026-07-17 | 4 | LO FRANCIS — Chief People Officer | Option exercise (M): 59,374 @ $7.80 · Option exercise (M): 23,677 @ $12.14 · Option exercise (M): 22,711 @ $8.46 · Sale (S): 105,762 @ $22.59 · Option exercise (M): 59,374 (derivative) @ $0 · Option exercise (M): 23,677 (derivative) @ $0 · +1 more | EDGAR |
| 2026-07-07 | 4 | ROBINS HARLAN S — Chief Scientific Officer | Sale (S): 239,351 @ $21.74 · Sale (S): 146,889 @ $22.45 | EDGAR |
| 2026-07-06 | 4 | BOBULSKY SUSAN — Chief Commercial Officer, MRD | Sale (S): 487 @ $22 | EDGAR |
| 2026-07-06 | 4 | LO FRANCIS — Chief People Officer | Option exercise (M): 3,500 @ $7.80 · Option exercise (M): 3,300 @ $12.14 · Option exercise (M): 12,206 @ $8.46 · Option exercise (M): 4,688 @ $3.99 · Option exercise (M): 14,064 @ $8.12 · Sale (S): 8,743 @ $22.18 · +13 more | EDGAR |
| 2026-06-30 | 4 | BENZENO SHARON — Chief Commercial Ofc Imm Med | Option exercise (M): 11,034 @ $12.14 · Sale (S): 11,034 @ $21 · Option exercise (M): 1,837 @ $12.14 · Option exercise (M): 24,944 @ $8.46 · Option exercise (M): 24,944 @ $3.99 · Option exercise (M): 51,570 @ $8.12 · +6 more | EDGAR |
| 2026-06-29 | 4 | BOBULSKY SUSAN — Chief Commercial Officer, MRD | Sale (S): 5,000 @ $20.50 | EDGAR |
| 2026-06-29 | 4 | GRIFFIN MICHELLE RENEE — Director | Option exercise (M): 52,084 @ $7.80 · Sale (S): 52,084 @ $20.18 · Option exercise (M): 52,084 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | ROBINS HARLAN S — Chief Scientific Officer | Sale (S): 100,000 @ $17.37 · Sale (S): 6,160 @ $18.01 | EDGAR |
| 2026-06-15 | 4 | BOBULSKY SUSAN — Chief Commercial Officer, MRD | Sale (S): 5,000 @ $19 | EDGAR |
| 2026-06-08 | 4 | BOBULSKY SUSAN — Chief Commercial Officer, MRD | Sale (S): 11,000 @ $18 | EDGAR |
| 2026-06-08 | 4 | LO FRANCIS — Chief People Officer | Option exercise (M): 5,792 @ $12.14 · Option exercise (M): 2,009 @ $8.46 · Option exercise (M): 2,344 @ $3.99 · Option exercise (M): 9,376 @ $8.12 · Sale (S): 39,741 @ $17.49 · Option exercise (M): 5,792 (derivative) @ $0 · +3 more | EDGAR |
| 2026-05-20 | 4 | PISKEL KYLE — Chief Financial Officer | Sale (S): 3,115 @ $13.04 | EDGAR |
| 2026-04-29 | 4 | RUBINSTEIN JULIE — President and COO | Option exercise (M): 14,707 @ $8.46 · Sale (S): 19,037 @ $14.23 · Option exercise (M): 14,707 (derivative) @ $0 | EDGAR |
| 2026-04-24 | 4 | RUBINSTEIN JULIE — President and COO | Option exercise (M): 14,722 @ $8.46 · Sale (S): 19,060 @ $14.13 · Option exercise (M): 14,722 @ $8.46 · Sale (S): 19,060 @ $13.74 · Option exercise (M): 14,722 @ $8.46 · Sale (S): 19,060 @ $14.02 · +3 more | EDGAR |
| 2026-04-21 | 4 | RUBINSTEIN JULIE — President and COO | Option exercise (M): 14,722 @ $8.46 · Sale (S): 19,060 @ $14.57 · Option exercise (M): 14,722 @ $8.46 · Sale (S): 19,060 @ $14.55 · Option exercise (M): 14,722 @ $8.46 · Option exercise (M): 11,881 @ $12.14 · +5 more | EDGAR |
| 2026-04-16 | 4 | RUBINSTEIN JULIE — President and COO | Option exercise (M): 14,722 @ $8.46 · Sale (S): 19,060 @ $14.56 · Option exercise (M): 14,722 @ $8.46 · Sale (S): 19,060 @ $14.61 · Option exercise (M): 14,722 @ $8.46 · Sale (S): 19,060 @ $14.18 · +3 more | EDGAR |
| 2026-04-13 | 4 | RUBINSTEIN JULIE — President and COO | Option exercise (M): 14,722 @ $7.27 · Sale (S): 16,960 @ $13.79 · Sale (S): 2,100 @ $14.44 · Option exercise (M): 14,722 @ $7.27 · Sale (S): 18,660 @ $12.75 · Sale (S): 400 @ $13.48 · +8 more | EDGAR |
| 2026-04-10 | 4 | ROBINS HARLAN S — Chief Scientific Officer | Sale (S): 10,000 @ $14.85 | EDGAR |
| 2026-04-10 | 4 | LO FRANCIS — Chief People Officer | Option exercise (M): 2,344 @ $3.99 · Sale (S): 22,564 @ $15.07 · Option exercise (M): 2,344 (derivative) @ $0 | EDGAR |
| 2026-04-08 | 4 | RUBINSTEIN JULIE — President and COO | Option exercise (M): 14,722 @ $7.27 · Sale (S): 19,060 @ $14.33 · Option exercise (M): 14,722 @ $7.27 · Sale (S): 19,060 @ $13.56 · Option exercise (M): 14,722 @ $7.27 · Option exercise (M): 11,881 @ $12.14 · +6 more | EDGAR |
| 2026-04-08 | 4 | ROBINS CHAD M — CEO and Chairman, Director | Sale (S): 83,332 @ $14.41 · Sale (S): 37,263 @ $15.19 | EDGAR |
| 2026-04-02 | 4 | RUBINSTEIN JULIE — President and COO | Option exercise (M): 14,722 @ $7.27 · Sale (S): 19,060 @ $14.45 · Option exercise (M): 14,722 @ $7.27 · Sale (S): 19,060 @ $14.60 · Option exercise (M): 14,722 (derivative) @ $0 · Option exercise (M): 14,722 (derivative) @ $0 | EDGAR |
| 2026-03-31 | 4 | RUBINSTEIN JULIE — President and COO | Option exercise (M): 14,722 @ $7.27 · Sale (S): 2,738 @ $12.49 · Sale (S): 16,322 @ $13.48 · Option exercise (M): 14,722 @ $7.27 · Sale (S): 19,060 @ $12.63 · Option exercise (M): 14,722 @ $7.27 · +4 more | EDGAR |
| 2026-03-26 | 4 | RUBINSTEIN JULIE — President and COO | Option exercise (M): 14,722 @ $7.27 · Sale (S): 19,060 @ $13.70 · Option exercise (M): 14,722 @ $7.27 · Sale (S): 19,060 @ $14.27 · Option exercise (M): 14,722 @ $7.27 · Sale (S): 19,060 @ $14.12 · +3 more | EDGAR |
Recent 8-K events — Adaptive Biotechnologies Corp
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-04 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-29 | 8-K | 2.02 — Results of Operations and Financial Condition 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-22 | 8-K | 1.01 — Entry into a Material Definitive Agreement 1.02 — Termination of a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-15 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-09 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-12 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-30 | 8-K | 8.01 — Other Events | EDGAR |
| 2025-11-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ADPT returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs